Profile data is unavailable for this security.
About the company
Silk Road Medical, Inc. is a medical device company that is focused on reducing the risk of stroke and its impact. The Company has developed an approach for the treatment of carotid artery disease called TransCarotid Artery Revascularization (TCAR). TCAR is a clinically proven procedure combining surgical principles of neuroprotection with minimally invasive endovascular techniques to treat blockages in the carotid artery at risk of causing a stroke. Its product portfolio consists of five single-use components: ENROUTE Transcarotid Neuroprotection System, ENROUTE Transcarotid Stent System, ENHANCE Transcarotid Peripheral Access Kit, ENROUTE 0.014'' Guidewire and ENROUTE Enflate Transcarotid RX Balloon Dilation Catheter. It manufactures ENROUTE NPS and ENROUTE NPS PLUS, or its ENROUTE NPS products, at its facilities in Sunnyvale, California and Plymouth, Minnesota. These facilities provide an aggregate of over 35,000 square feet of space for its production and distribution operations.
- Revenue in USD (TTM)177.13m
- Net income in USD-55.74m
- Incorporated2007
- Employees474.00
- LocationSilk Road Medical Inc1213 Innsbruck DrSUNNYVALE 94089-1317United StatesUSA
- Phone+1 (650) 566-9060
- Fax+1 (302) 655-5049
- Websitehttps://silkroadmed.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Iradimed Corp | 65.56m | 17.19m | 511.07m | 148.00 | 29.88 | 7.15 | 28.46 | 7.80 | 1.35 | 1.35 | 5.15 | 5.64 | 0.738 | 1.69 | 5.14 | 442,988.50 | 19.35 | 13.16 | 22.51 | 14.58 | 76.50 | 76.55 | 26.22 | 21.46 | 3.87 | -- | 0.00 | 68.13 | 23.00 | 16.59 | 34.02 | 22.22 | 97.77 | -- |
| Nano-X Imaging Ltd | 9.91m | -60.78m | 524.05m | 180.00 | -- | 2.68 | -- | 52.91 | -1.08 | -1.08 | 0.1758 | 3.38 | 0.0419 | -- | 8.05 | -- | -25.72 | -30.98 | -28.14 | -35.10 | -66.55 | -- | -613.59 | -1,527.24 | 5.56 | -- | 0.0175 | -- | 15.47 | -- | 46.33 | -- | 114.35 | -- |
| Embecta Corp | 1.12bn | 55.30m | 595.94m | 2.20k | 10.78 | -- | 6.63 | 0.531 | 0.9598 | 0.9598 | 19.47 | -13.78 | 0.9296 | 2.57 | 19.35 | 510,181.80 | 4.58 | -- | 6.44 | -- | 66.55 | -- | 4.93 | -- | 1.75 | 1.67 | 1.94 | -- | -0.7703 | -- | -68.52 | -- | -- | -- |
| Fulgent Genetics Inc | 289.21m | -167.83m | 601.30m | 1.18k | -- | 0.5249 | -- | 2.08 | -5.64 | -5.64 | 9.71 | 38.31 | 0.2207 | -- | 5.57 | 244,267.70 | -13.37 | 16.70 | -14.25 | 18.37 | 36.12 | 67.89 | -60.59 | 29.06 | -- | -- | 0.0048 | 0.00 | -53.27 | 68.41 | -217.03 | -- | 57.08 | -- |
| Jin Medical International Ltd | 19.98m | 3.25m | 623.06m | 269.00 | 178.32 | 26.20 | 174.12 | 31.19 | 0.0223 | 0.0223 | 0.1353 | 0.1519 | 0.7557 | 1.85 | 5.00 | 74,260.52 | 12.28 | -- | 16.62 | -- | 33.02 | -- | 16.25 | -- | 3.02 | -- | 0.0582 | -- | -7.58 | -- | 2.84 | -- | -- | -- |
| SI-Bone Inc | 138.89m | -43.34m | 628.29m | 344.00 | -- | 3.68 | -- | 4.52 | -1.13 | -1.13 | 3.62 | 4.16 | 0.716 | 1.57 | 6.52 | 403,738.40 | -22.34 | -27.88 | -25.24 | -30.94 | 78.78 | 85.03 | -31.20 | -51.09 | 8.15 | -- | 0.1756 | -- | 30.52 | 20.19 | 29.25 | -- | 52.62 | -- |
| Atrion Corp | 169.33m | 19.41m | 678.81m | 712.00 | 35.00 | 2.79 | 19.67 | 4.01 | 11.02 | 11.02 | 96.13 | 138.01 | 0.6444 | 1.44 | 7.21 | 237,817.40 | 7.39 | 11.96 | 7.85 | 12.62 | 36.84 | 41.99 | 11.46 | 19.05 | 2.57 | 92.92 | 0.00 | 42.42 | -7.73 | 2.12 | -44.55 | -10.74 | 4.98 | 11.27 |
| Silk Road Medical Inc | 177.13m | -55.74m | 682.42m | 474.00 | -- | 4.51 | -- | 3.85 | -1.44 | -1.44 | 4.56 | 3.86 | 0.6622 | 2.04 | 8.52 | 373,700.40 | -20.84 | -29.02 | -23.22 | -32.98 | 71.75 | 72.91 | -31.47 | -46.84 | 6.97 | -- | 0.3335 | -- | 27.77 | 38.66 | -1.33 | -- | -7.92 | -- |
| Varex Imaging Corp | 877.80m | 44.60m | 686.95m | 2.30k | 25.21 | 1.21 | 8.70 | 0.7826 | 0.6712 | 0.6712 | 16.65 | 14.01 | 0.7245 | 1.95 | 5.90 | 365,750.00 | 3.72 | 0.9913 | 4.32 | 1.18 | 32.37 | 31.70 | 5.14 | 1.36 | 2.37 | 2.85 | 0.4322 | -- | 3.96 | 2.93 | 59.08 | 18.88 | 0.2924 | -- |
| Treace Medical Concepts Inc | 187.12m | -49.53m | 698.02m | 516.00 | -- | 5.05 | -- | 3.73 | -0.8154 | -0.8154 | 3.08 | 2.23 | 0.9107 | 1.45 | 5.56 | 362,631.80 | -24.10 | -- | -29.51 | -- | 81.20 | -- | -26.47 | -- | 3.76 | -- | 0.2776 | -- | 31.92 | -- | -15.68 | -- | -- | -- |
| Orthopediatrics Corp | 148.73m | -20.97m | 700.74m | 247.00 | -- | 1.83 | -- | 4.71 | -0.9251 | -0.9251 | 6.56 | 16.13 | 0.3433 | 0.4073 | 5.01 | 602,153.90 | -4.84 | -5.40 | -5.28 | -5.93 | 74.80 | 75.09 | -14.10 | -15.92 | 2.90 | -- | 0.026 | -- | 21.62 | 20.91 | -1,767.25 | -- | 28.29 | -- |
| BioLife Solutions Inc | 143.27m | -66.43m | 718.46m | 409.00 | -- | 2.12 | -- | 5.01 | -1.52 | -1.52 | 3.28 | 7.48 | 0.332 | 2.46 | 5.45 | 350,298.30 | -15.40 | -13.76 | -17.12 | -15.04 | 32.63 | 36.76 | -46.36 | -42.99 | 1.83 | -30.52 | 0.0733 | -- | -11.43 | 48.65 | 52.49 | -- | 86.35 | -- |
| Cytek Biosciences Inc | 193.01m | -12.15m | 779.71m | 676.00 | -- | 1.98 | -- | 4.04 | -0.0887 | -0.0887 | 1.43 | 3.01 | 0.3807 | 1.53 | 3.68 | 285,523.70 | -2.40 | -- | -2.67 | -- | 56.69 | -- | -6.29 | -- | 5.89 | -- | 0.0056 | -- | 17.67 | -- | -571.58 | -- | -- | -- |
| Paragon 28 Inc | 216.39m | -47.84m | 800.04m | 430.00 | -- | 4.50 | -- | 3.70 | -0.5819 | -0.5819 | 2.64 | 2.15 | 0.7276 | 0.5484 | 5.77 | 503,230.20 | -16.09 | -- | -20.14 | -- | 79.85 | -- | -22.11 | -- | 2.30 | -7.22 | 0.3832 | -- | 19.30 | -- | 28.94 | -- | -- | -- |
| Artivion Inc | 354.00m | -30.57m | 842.95m | 1.50k | -- | 2.95 | -- | 2.38 | -0.7496 | -0.7496 | 8.68 | 6.86 | 0.4553 | 1.60 | 5.30 | 236,002.70 | -3.95 | -2.20 | -4.24 | -2.36 | 64.74 | 65.51 | -8.67 | -5.34 | 3.43 | 0.6809 | 0.5246 | -- | 12.82 | 6.14 | -60.09 | -- | 5.13 | -- |
| Perspective Therapeutics Inc | 8.17m | -25.10m | 862.77m | 88.00 | -- | 4.18 | -- | 105.59 | -0.1012 | -0.1012 | 0.0351 | 0.352 | 0.0944 | 4.91 | 5.55 | 92,852.27 | -29.01 | -- | -31.19 | -- | 22.96 | -- | -307.18 | -- | 2.55 | -- | 0.0173 | -- | -- | -- | -- | -- | -- | -- |
Data as of Apr 19 2024. Currency figures normalised to Silk Road Medical Inc's reporting currency: US Dollar USD
58.00%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Wasatch Advisors, Inc.as of 31 Dec 2023 | 4.05m | 10.34% |
| Capital Research & Management Co. (World Investors)as of 31 Dec 2023 | 2.97m | 7.57% |
| The Vanguard Group, Inc.as of 31 Dec 2023 | 2.81m | 7.18% |
| BlackRock Fund Advisorsas of 31 Dec 2023 | 2.78m | 7.10% |
| Goldman Sachs & Co. LLC (Private Banking)as of 31 Dec 2023 | 1.98m | 5.05% |
| Jefferies Investment Advisers LLCas of 31 Dec 2023 | 1.91m | 4.87% |
| Armistice Capital LLCas of 31 Dec 2023 | 1.77m | 4.51% |
| Morgan Stanley & Co. LLCas of 31 Dec 2023 | 1.52m | 3.87% |
| D. E. Shaw & Co. LPas of 31 Dec 2023 | 1.50m | 3.84% |
| Bellevue Asset Management AGas of 31 Dec 2023 | 1.44m | 3.67% |
More ▼
Data from 31 Dec 2023 - 31 Dec 2023Source: FactSet Research Systems Inc.
